COPD

News

AZ sees triple approval in Japan for cancer and COPD drugs

AstraZeneca has seen three of its drugs approved by the Japanese regulator – a new indication for its cancer drug Lynparza, and two new combination therapies for patients with chronic obstr

News

Novartis builds case for asthma drugs to challenge GSK

Novartis has positive data for a two-drug asthma regimen that forms the backbone of its efforts to take on rival GlaxoSmithKline in the respiratory market.

News

Boehringer looks to enhance COPD care with new registry

Boehringer Ingelheim and Optimum Patient Care are launching a new patient registry, APEX COPD (Advancing the Patient Experience in COPD), to better understan

News

Study aims to identify digital predictors of COPD exacerbati...

Spire Health has launched a research study on COPD exacerbations using continuous respiratory sensors to assess adherence and identify digital biomarkers preceding exacerbations.

News

Mylan launches Advair generic at 70% discount in US

Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug.

News

AZ's new COPD inhaler Bevespi Aerosphere approved in EU

AstraZeneca’s new inhaler Bevespi Aerosphere (glycopyrronium/formoterol fumarate) has been approved in Europe, as a maintenance treatment for chronic obstructive pulmonary disease (COPD).

AZ sees triple approval in Japan for cancer and COPD drugs

Novartis builds case for asthma drugs to challenge GSK

Boehringer looks to enhance COPD care with new registry

Study aims to identify digital predictors of COPD exacerbati...

Mylan launches Advair generic at 70% discount in US

AZ's new COPD inhaler Bevespi Aerosphere approved in EU

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

COPD

Editor's Picks